ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1127

Risk of Ocular Inflammatory Conditions in Patients with Autoimmune Diseases: A Retrospective Study Using the National Inpatient Sample

Sami Rabah and Xiangyi Kang, Lincoln Medical Center, New York, NY

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, Eye Disorders

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Autoimmune diseases are known to cause various ocular inflammatory conditions and are often the initial presentation in many of these diseases. This study aims to investigate the demographic characteristics of patients with ocular inflammatory conditions, the prevalence of autoimmune diseases in these patients, and the odds of having an ocular disease if diagnosed with an autoimmune disease, using data from the Nationwide Inpatient Sample (NIS) database.

Methods: Patients who were 18 or older, and were hospitalized between January 1, 2016, and December 31, 2019, with an ocular condition including Episcleritis Scleritis or Uveitis, were identified from the National Inpatient Sample (NIS) database using the International Classification of Diseases, Tenth Revision (ICD-10) codes. Demographic characteristics including mean age, sex distribution, and racial composition were examined for each ocular condition. Prevalence rates of autoimmune and systemic diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and Sjogren’s syndrome, were calculated for each ocular condition. The adjusted odds ratios (ORs) were calculated using logistic multivariate regression analysis, controlling for age, race, sex, possible infections, and other comorbidities, to assess the associations between autoimmune diseases and ocular inflammatory conditions.

Results:  

The mean age varied across different ocular conditions, with posterior uveitis patients being the youngest (mean age: 46.1 years) and intermediate uveitis patients being the oldest (mean age: 59.3 years). Females were predominant in all ocular conditions, ranging from 45.7% in posterior uveitis to 60% in scleritis. Whites constituted the majority racial group across all ocular conditions, while the prevalence of autoimmune and systemic diseases varied. RA and inflammatory bowel disease were commonly observed across all ocular conditions, with RA being observed in 12.9% and 8.9% of patients with scleritis and episcleritis respectively. 

 

The adjusted odds ratios revealed significant associations between autoimmune diseases and inflammatory ocular conditions. Notably, Behçet’s disease exhibited significantly increased odds of episcleritis (OR 33.9, p < 0.001) and intermediate uveitis (OR 50, p < 0.001). Relapsing polychondritis showed a high odds ratio for scleritis (OR 202, p < 0.001). RA and SLE were associated with increased odds of developing scleritis (OR 6.2 and 3.4, respectively; both p < 0.001) and episcleritis (OR 3.8 for both, p < 0.001). Other notable findings include patients with granulomatosis with polyangiitis having higher odds of developing scleritis (OR 106.5, p < 0.001) and episcleritis (OR 89.5, p < 0.001), as well as a strong association for patients with sarcoidosis to develop anterior uveitis (OR 13.1, p =0.006)

 

Results are summarized in Tables 1 and 2

Conclusion: Our retrospective analysis reveals that patients with autoimmune diseases have a higher risk of developing inflammatory ocular conditions. This underscores the importance of regular eye examinations for individuals with autoimmune diseases to ensure early detection and management of potential ocular complications.

Supporting image 1

Supporting image 2


Disclosures: S. Rabah: None; X. Kang: None.

To cite this abstract in AMA style:

Rabah S, Kang X. Risk of Ocular Inflammatory Conditions in Patients with Autoimmune Diseases: A Retrospective Study Using the National Inpatient Sample [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/risk-of-ocular-inflammatory-conditions-in-patients-with-autoimmune-diseases-a-retrospective-study-using-the-national-inpatient-sample/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-of-ocular-inflammatory-conditions-in-patients-with-autoimmune-diseases-a-retrospective-study-using-the-national-inpatient-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology